Cardura

Cardura is the brand name for the medication doxazosin, which belongs to a class of drugs known as alpha-1 adrenergic blockers. It is primarily used to treat conditions related to prostate enlargement and hypertension. Doxazosin works by relaxing the muscles in the blood vessels and the prostate, which helps to improve blood flow and reduce urinary symptoms associated with benign prostatic hyperplasia (BPH).

Traditionally prescribed for men with BPH, Cardura alleviates urinary issues such as difficulty in starting urination, weak stream, and the need to urinate frequently or urgently. It is also used to manage high blood pressure (hypertension), either alone or in combination with other antihypertensive medications. By relaxing vascular smooth muscle, doxazosin helps lower blood pressure, thus reducing the risk of cardiovascular events.

Cardura is typically administered orally in tablet form, with dosages varying based on the condition being treated and patient response. Common side effects may include dizziness, fatigue, headache, and nasal congestion. Because of its vasodilatory effects, precautions are necessary to minimize the risk of orthostatic hypotension—sudden blood pressure drops upon standing.

The medication should be used under medical supervision, especially in patients with a history of heart problems or other underlying health conditions. It is important for individuals taking Cardura to follow prescribed dosing schedules and report any adverse effects to their healthcare provider.

Doxazosin, including the formulations marketed as Cardura, has been in medical use since the late 20th century and remains a standard treatment option for BPH and hypertension, with ongoing research exploring its broader cardiovascular implications.